Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Evolent Health, Inc.
Next earnings Aug 5, 2026 (after close) · consensus $-0.02 EPS, $604M rev
Last earnings +11.5% on 2026-05-07
Revenue fell -26.6% YoY.
Evolent Health, Inc. shows $1.88B in FY2025 revenue (-26.6% YoY), a -28.5% net margin, and -128.7% ROE.
Sources: SEC EDGAR (CIK 0001628908, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 1:42:18 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $908M | $1.35B | $1.96B | $2.55B | $1.88B |
| Gross profit | — | — | — | — | — |
| Operating income | -$42.4M | $3.64M | -$71.2M | -$40.5M | -$410M |
| Net income | -$37.6M | -$19.2M | -$113M | -$61.6M | -$535M |
| Diluted EPS | -$0.44 | -$0.20 | -$1.28 | -$0.81 | -$5.07 |
| Net margin | -4.1% | -1.4% | -5.8% | -2.4% | -28.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
| 2026-06-04 | Ajayi Toyin Director | Award | 41.1K | |
| 2026-06-04 | Glass Russell Monroe Director | Award | 41.1K | |
| 2026-06-04 | GRUA PETER J Director | Award | 41.1K | |
| 2026-06-04 | GUERTIN SHAWN M Director | Award | 41.1K | |
| 2026-06-04 | Jelinek Richard M Director | Award | 41.1K | |
| 2026-06-04 | KECK KIM Director | Award | 41.1K | |
| 2026-06-04 | Smith Jill D. Director | Award | 41.1K | |
| 2026-06-04 | Springstubb Brendan B Director | Award | 41.1K |